GoKawiilBill Ackman funds experimental mitochondrial transplant for daughter's vision loss
After his daughter Lucy suffered a brain hemorrhage that left her blind, billionaire Bill Ackman used his connections to secure her advanced care at Mount Sinai and pursue an experimental treatment. In May, the FDA granted her medical team first-time emergency authorization to transplant mitochondria from her leg muscle into her eyes in an attempt to repair her optic nerves. Ackman has since pledged over $400 million to establish an institute focused on longevity and brain health research.
GoKawiil's interpretation of the reporting above, not reported fact.
This case illustrates how wealthy individuals are increasingly shaping the direction of biomedical research through personal funding, especially as federal science budgets shrink under the current administration. It also puts a spotlight on mitochondrial transplantation, an experimental technique with implications well beyond one family's crisis, potentially informing future treatments for nerve damage and vision loss. The story adds to a broader pattern of tech and finance billionaires like Sam Altman and Jeff Bezos funding longevity science outside traditional institutional channels.
- Ackman's daughter received FDA emergency authorization for an experimental mitochondrial transplant to treat vision loss.
- Ackman is committing over $400 million to a new institute focused on longevity and brain health.
- The case reflects a growing trend of billionaires personally funding cutting-edge medical research as government funding declines.
Source: science.slashdot.org — Posted, 2026-09-07
Published there as: “'She Lost Her Sight. Her Billionaire Father Bet On a Daring New Treatment.'”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.